We are live on ! Find out more
OPK icon

Opko Health

219 hedge funds and large institutions have $1.38B invested in Opko Health in 2015 Q2 according to their latest regulatory filings, with 58 funds opening new positions, 77 increasing their positions, 51 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more funds holding in top 10

Funds holding in top 10: 25 (+3)

100% more first-time investments, than exits

New positions opened: 58 | Existing positions closed: 29

51% more repeat investments, than reductions

Existing positions increased: 77 | Existing positions reduced: 51

22% more capital invested

Capital invested by funds: $1.14B → $1.38B (+$245M)

15% more funds holding

Funds holding: 191219 (+28)

0.68% more ownership

Funds ownership: 17.88%18.55% (+0.68%)

52% less call options, than puts

Call options by funds: $157M | Put options by funds: $327M

Holders
219
Holders Change
+28
Holders Change %
+14.66%
% of All Funds
5.9%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.13%
New
58
Increased
77
Reduced
51
Closed
29
Calls
$157M
Puts
$327M
Net Calls
-$170M
Net Calls Change
-$122M
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$244M +$18.7M +1,200,954 +9%
BIT
2
BlackRock Institutional Trust
California
$95.5M +$2.43M +156,529 +3%
OIM
3
Oracle Investment Management
Connecticut
$79.7M
State Street
4
State Street
Massachusetts
$63.7M -$13.3M -853,721 -18%
Fidelity Investments
5
Fidelity Investments
Massachusetts
$53.2M
MMH
6
Menora Mivtachim Holdings
Israel
$43.8M -$31 -2 -0%
Northern Trust
7
Northern Trust
Illinois
$33M -$4.67M -300,255 -13%
BFA
8
BlackRock Fund Advisors
California
$30.7M -$50.3M -3,235,251 -63%
Renaissance Technologies
9
Renaissance Technologies
New York
$30.7M +$10.2M +654,100 +52%
Morgan Stanley
10
Morgan Stanley
New York
$30.3M +$11.3M +724,529 +62%
Invesco
11
Invesco
Georgia
$29.8M +$9.36M +602,065 +48%
Norges Bank
12
Norges Bank
Norway
$27.1M +$8.86M +569,550 +51%
Goldman Sachs
13
Goldman Sachs
New York
$25.4M -$44M -2,830,140 -64%
Two Sigma Investments
14
Two Sigma Investments
New York
$24.7M +$23.6M +1,516,803 +9,308%
Bank of America
15
Bank of America
North Carolina
$24.1M +$13.8M +887,368 +146%
D.E. Shaw & Co
16
D.E. Shaw & Co
New York
$23M +$22M +1,413,655 +7,362%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$22.2M +$154K +9,903 +0.7%
Dimensional Fund Advisors
18
Dimensional Fund Advisors
Texas
$21M +$879K +56,512 +5%
Susquehanna International Group
19
Susquehanna International Group
Pennsylvania
$19.8M +$7.79M +501,106 +69%
CI
20
Clal Insurance
Israel
$18.9M
Deutsche Bank
21
Deutsche Bank
Germany
$17.9M +$8.5M +546,695 +97%
JG
22
Jefferies Group
New York
$17.8M -$996K -64,061 -5%
GC
23
Guggenheim Capital
Illinois
$17.2M +$62.2K +4,000 +0.4%
TCIM
24
TIAA CREF Investment Management
New York
$16.5M +$2.02M +129,575 +14%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$15.3M -$2.84M -182,340 -16%

OPK Hedge Fund Activity: Q2 2015 in Review

219 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Opko Health (OPK) for Q2 2015, worth a combined $1.38B — up 22% from $1.14B a quarter earlier.

Buyers outnumbered sellers: 58 funds opened new OPK positions and 29 closed out — a net gain of 29 holders — while 77 added to existing stakes and 51 trimmed.

The largest buyer was Two Sigma Investments, adding an estimated $23.6M. The largest seller was BlackRock Fund Advisors, cutting an estimated $50.3M.

  • 219 institutional investors held Opko Health (OPK) as of Q2 2015, up from 191 in Q1 2015.
  • Funds reported $1.38B of Opko Health stock for Q2 2015, up 22% quarter-over-quarter.
  • 58 funds opened new Opko Health positions in Q2 2015 and 29 closed out, a net change of +29 holders.
  • The largest Opko Health buyer in Q2 2015 was Two Sigma Investments, an estimated $23.6M added.
  • The largest Opko Health seller in Q2 2015 was BlackRock Fund Advisors, an estimated $50.3M sold.

Based on aggregated 13F filings for Q2 2015.